GENE ONLINE|News &
Opinion
Blog

In-Depth
ESMO 2022: Promising Trials Highlights That Are Worth Following
2022-09-21
2026: The Promise of Synthetic Biology
2022-08-11
Innovating Drug Delivery Systems with Moderna’s Bob Langer
2022-07-26
Roe Reversal May Cause Downstream Issues in Repurposing Mifepristone
2022-06-27
Ushering In A New Generation Of AI-Focused Investments Opportunities
2022-06-14
Recounting 25 Years of Genetic and Human Diversity Discovery With deCODE Founder Kari Stefansson
2022-05-26
Fennec Submits Hearing Loss Drug for Third Time After Prior FDA Approval Rejections
2022-04-28
AACR 2022: Roadmap to a Successful Biotech Start-up Journey
2022-04-16
New Approaches to Effectively Manage Hemophilia in Pregnant Women
2022-04-15
The Renaissance of Psychedelics Research: An Interview with the CEO of MindMed, Rob Barrow
2022-04-12
AACR 2022 Opening: Decoding Cancer Complexity to Transform Patient Outcomes
2022-04-12
Compensating for OxyContin: The Harm from Pharma
2022-04-12
Insider: Groundbreaking Malaria Vaccine Reinvigorates the Fight against Disease
2022-03-30
Sudden Death in Infants Could Have a Genetic Basis
2022-03-29
Market Insight on FDA-approvals: Rise of First-in-class and Regenerative Innovations
2022-03-17
1 2 3 8
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!